Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.

The New England Journal of Medicine
STARRT-AKI InvestigatorsAlexander Zarbock

Abstract

Acute kidney injury is common in critically ill patients, many of whom receive renal-replacement therapy. However, the most effective timing for the initiation of such therapy remains uncertain. We conducted a multinational, randomized, controlled trial involving critically ill patients with severe acute kidney injury. Patients were randomly assigned to receive an accelerated strategy of renal-replacement therapy (in which therapy was initiated within 12 hours after the patient had met eligibility criteria) or a standard strategy (in which renal-replacement therapy was discouraged unless conventional indications developed or acute kidney injury persisted for >72 hours). The primary outcome was death from any cause at 90 days. Of the 3019 patients who had undergone randomization, 2927 (97.0%) were included in the modified intention-to-treat analysis (1465 in the accelerated-strategy group and 1462 in the standard-strategy group). Of these patients, renal-replacement therapy was performed in 1418 (96.8%) in the accelerated-strategy group and in 903 (61.8%) in the standard-strategy group. At 90 days, death had occurred in 643 patients (43.9%) in the accelerated-strategy group and in 639 (43.7%) in the standard-strategy group (rela...Continue Reading

References

Aug 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Kathleen D LiuGlenn M Chertow
Mar 11, 2009·Journal of Critical Care·Sean M BagshawUNKNOWN Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators
May 4, 2010·Nature Medicine·Li YangJoseph V Bonventre
Apr 12, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M HerdmanX Badia
Dec 28, 2012·The New England Journal of Medicine·Ashita Tolwani
Aug 12, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Suvi T VaaraUNKNOWN FINNAKI Study Group
Nov 8, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Alexandre Braga LibórioCandice Torres de Melo Bezerra
Jul 15, 2015·Kidney International·Ron WaldUNKNOWN Canadian Critical Care Trials Group
Jul 15, 2015·Intensive Care Medicine·Eric A J HosteJohn A Kellum
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Mervyn SingerDerek C Angus
May 18, 2016·The New England Journal of Medicine·Stéphane GaudryUNKNOWN AKIKI Study Group
Nov 12, 2016·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ron WaldSean M Bagshaw
Feb 28, 2018·The New England Journal of Medicine·Matthew W SemlerUNKNOWN SMART Investigators and the Pragmatic Critical Care Research Group
Oct 12, 2018·The New England Journal of Medicine·Saber D BarbarUNKNOWN IDEAL-ICU Trial Investigators and the CRICS TRIGGERSEP Network
May 6, 2019·Journal of the American Society of Nephrology : JASN·Raanan MarantsChristopher W McIntyre

❮ Previous
Next ❯

Citations

Sep 11, 2020·Nature Reviews. Nephrology·Josée Bouchard, Ravindra Mehta
Sep 10, 2020·Nature Reviews. Nephrology·Edward G ClarkMichael Joannidis
Aug 23, 2020·Journal of Clinical Medicine·Joana GameiroJosé António Lopes
Aug 7, 2020·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Akash Deep
Oct 29, 2020·The New England Journal of Medicine·Thomas W F LuijnenburgAnne-Cornélie J M de Pont
Nov 4, 2020·Expert Review of Anti-infective Therapy·Nicholas HemingDjillali Annane
Nov 5, 2020·Der Internist·K StahlJ Schmidt
Dec 2, 2020·BMC Nephrology·Nuttha LumlertgulMarlies Ostermann
Dec 9, 2020·Zeitschrift für Gastroenterologie·Florian Gunnar ScurtChristos Chatzikyrkou
Jan 4, 2021·Critical Care : the Official Journal of the Critical Care Forum·Emily J See, Rinaldo Bellomo
Jan 19, 2021·Paediatrics and International Child Health·Apurva TomarAbhijeet Saha
Dec 19, 2020·Nature Reviews. Nephrology·Anitha Vijayan
Oct 29, 2020·The New England Journal of Medicine·Ron WaldUNKNOWN STARRT-AKI Investigators
Dec 29, 2020·Der Nephrologe·Jan-Hendrik B HardenbergKai M Schmidt-Ott
Sep 14, 2020·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ryann SohaneyMichael Heung
Feb 21, 2021·Seminars in Dialysis·Emily SeeRinaldo Bellomo
Feb 9, 2021·Critical Care Medicine·Rinaldo BellomoJohn A Kellum
Mar 7, 2021·Journal of Clinical Medicine·Luis Sanchez-RussoPaolo Cravedi
Mar 10, 2021·KI Reports·Faeq Husain-SyedClaudio Ronco
Mar 27, 2021·Current Opinion in Nephrology and Hypertension·Alejandro Y Meraz-MuñozRon Wald
Mar 24, 2021·Critical Care Clinics·Sean M Bagshaw, Ron Wald
Mar 24, 2021·Critical Care Clinics·Javier A Neyra, Lakhmir S Chawla
Oct 8, 2020·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Valentine A Lobo
Apr 2, 2021·British Journal of Hospital Medicine·Ashley TomlinsonLui G Forni
Mar 30, 2021·Clinical Kidney Journal·Gregory L HundemerMark Canney
Apr 4, 2021·Seminars in Dialysis·Javier A Neyra, Kianoush Kashani
Apr 9, 2021·The American Journal of Hospice & Palliative Care·Sarah J RamerHolly G Prigerson
Apr 10, 2021·The Journal of Thoracic and Cardiovascular Surgery·Christina MassothUNKNOWN Progressive AKI Group
Apr 5, 2021·Lancet·Marlies Ostermann, Nuttha Lumlertgul
Apr 16, 2021·Annals of Intensive Care·Matthieu JammeGuillaume Geri
Apr 29, 2021·Seminars in Dialysis·Javier A Neyra, Ashita Tolwani
Oct 2, 2020·Current Opinion in Critical Care·Zaccaria RicciNuttha Lumlertgul
May 19, 2021·Seminars in Cardiothoracic and Vascular Anesthesia·Nirvik PalMiklos D Kertai
May 25, 2021·Current Opinion in Nephrology and Hypertension·Shweta PunjAneesha A Shetty
May 28, 2021·Critical Care : the Official Journal of the Critical Care Forum·Sean M BagshawRon Wald
Jun 2, 2021·Critical Care : the Official Journal of the Critical Care Forum·Matthew E CoveJohn A Kellum
Jun 2, 2021·Critical Care : the Official Journal of the Critical Care Forum·Sean M BagshawJohn A Kellum

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.